SCHEMBL6323629

SCHEMBL6323629

COc1ccc(-c2noc(N)c2C(=O)NCc2ccc(F)c(F)c2)cn1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.44
HDAC1 Q13547 1/20 0.44
LMNA P02545 1/20 0.43
ROCK2 O75116 1/20 0.42
ROCK1 Q13464 1/20 0.42
CDK2 P24941 1/20 0.42
GSK3B P49841 1/20 0.42
PDPK1 O15530 1/20 0.42
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 1/20 0.41
GABRA5 P31644 4/20 0.41
GABRA1 P14867 1/20 0.40
POLB P06746 1/20 0.40
RECQL P46063 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6323609 0.89 ADORA2A (0.48) HDAC1LMNAROCK2ROCK1CDK2
SCHEMBL6321897 0.88 SMN1; SMN2 (0.47) HDAC1LMNAMAPK1ALDH1A1POLB
SCHEMBL6323365 0.87 CDK2 (0.47) HDAC1LMNACDK2GSK3BALDH1A1
SCHEMBL6316520 0.87 MAPT (0.52) HDAC1LMNACDK2GSK3BALDH1A1
SCHEMBL6315498 0.86 POLB (0.52) HDAC1ROCK2ROCK1CDK2GSK3B
SCHEMBL6324039 0.85 ALDH1A1 (0.52) HDAC1LMNACDK2GSK3BMAPK1
SCHEMBL6316080 0.85 ALDH1A1 (0.48) HDAC1CDK2GSK3BALDH1A1MAPT
SCHEMBL6315541 0.85 GSK3B (0.46) HDAC1LMNACDK2GSK3BALDH1A1
SCHEMBL6324209 0.85 RECQL (0.58) ROCK2ROCK1ALDH1A1RECQLSMN1; SMN2
SCHEMBL6318699 0.84 TACR1 (0.44) HDAC1LMNACDK2GSK3BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 MET 3133/4885HDAC1 907/4885LMNA 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.